Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?

Area of Science:

• Oncology
• Bone Biology
• Cancer Metastasis

Background:

• Bone metastases arise from intricate interactions between cancer cells and the bone microenvironment.
• Cancer cells must navigate a multi-step process, including detachment, circulation, adhesion, and dormancy, to establish bone metastases.
• Tumor cells actively prime the bone microenvironment before arrival, involving metastasis-initiating cells and osteotropic factors.

Purpose of the Study:

• To review the molecular mechanisms underlying bone metastasis.
• To discuss the translation of research findings from the laboratory to clinical practice for bone metastasis.
• To highlight current therapeutic strategies for managing bone metastatic disease.

Main Methods:

• Literature review of studies on bone metastasis.
• Analysis of molecular mechanisms of cancer cell interaction with bone.
• Discussion of clinical applications of bone-targeted therapies.

Main Results:

• Bone metastases result from a complex interplay between cancer cells and the bone microenvironment.
• Therapies like bisphosphonates and denosumab effectively reduce bone resorption and associated morbidity.
• These agents show promise in reducing bone relapse in certain cancer settings, such as post-surgical breast cancer.

Conclusions:

• A deep understanding of bone metastasis mechanisms is crucial for developing targeted anti-tumoral therapies.
• Current effective treatments for bone metastases primarily involve bone-targeting agents that inhibit bone resorption.
• Translational research is advancing the clinical management of bone metastatic disease.